Cite
APA Citation
Garros-Regulez, L., Aldaz, P., Arrizabalaga, O., Moncho-Amor, V., Carrasco-Garcia, E., Manterola, L., Moreno-Cugnon, L., Barrena, C., Villanua, J., Ruiz, I., Pollard, S., Lovell-Badge, R., Sampron, N., Garcia, I., & Matheu, A. (n.d.). mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance. Expert opinion on therapeutic targets, 20, 393–405. http://access.bl.uk/ark:/81055/vdc_100031798633.0x000028